T-ZELL-REZEPTOREN

European patent · EP3642224 · In force

Register entry

Publication number
EP3642224
Application number
EP18738201
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 19, 2018
Published
Apr 29, 2020
Granted
Mar 22, 2023
Protection ends at the latest
Jun 18, 2038
Next annual fee due
Jun 30, 2027
IPC classes
C07K 14/725 (2006.01)
C07K 14/47 (2006.01)
A61K 39/00 (2006.01)
Priority
GB 201709866 20.06.2017
PCT application
PCT/EP2018/066287 19.06.2018
PCT publication
WO2018/234319 27.12.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jan 31, 2024

    Change

    Published in Swissreg on 31.01.2024

  5. Aug 26, 2023

    Change

    Published in Swissreg on 26.08.2023

  6. Mar 22, 2023

    Granted

    Published in Swissreg on 22.03.2023

Parties

Holder

Immunocore Limited

92 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, GB

Inventor

HARPER, Stephen

Abingdon Oxfordshire OX14 4RY, GB

ADDIS, Philip William

Abingdon Oxfordshire OX14 4RY, GB

BEDKE, Nicole Joy

Abingdon Oxfordshire OX14 4RY, GB

MAHON, Tara

Abingdon Oxfordshire OX14 4RY, GB

O'DWYER, Ronan Pádraic

Abingdon Oxfordshire OX14 4RY, GB

LIDDY, Nathaniel

Abingdon Oxfordshire OX14 4RY, GB

BOUARD, Lucie

Abingdon Oxfordshire OX14 4RY, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.